| Species Reactivity | Human |
| Host Cells | HEK293 cells |
| MW | 50 and 25 kDa for the heavy and light chains, respectively (150 kDa) |
| Isotype | Human IgG1, Kappa LC |
| Clonality | Monoclonal |
Lyophilized powder
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH7.5. Normally mannitol or trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
Avoid repeated freeze-thaw cycles.
This product is stable after storage at:
4 ℃ for 1 year in lyophilized state.
-70 ℃ for 3 months under sterile conditions after reconstitution.
A universal dual mechanism immunotherapy for the treatment of influenza virus infections
Authors: Liu X, Zhang B, Wang Y, et al.
Journal: Nature communications 2020
Application: Confocal microscopy
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
ACROBiosystems has developed a series of critical reagents for COVID-19 vaccine development and evaluation,including proteins, antibodies and kits. These featured products are suitable for IgG/M antibody titer detection, neutralizing antibody titer detection and antigen titer detection.
High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.
ACROBiosystems has developed a serial of high-quality antigen and antibody reagents, including super stable trimeric S protein, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity verified by inactivated virus samples.
ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.
This web search service is supported by Google Inc.
A-Z